Compare Multi Spunindo Jaya Tbk. (MSJA) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Multi Spunindo Jaya Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Multi Spunindo Jaya Tbk. trades at Rp825 (market cap 5.24T, 16.9M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Multi Spunindo Jaya Tbk. is far larger — about 50.2× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| MSJA | SCPI | |
|---|---|---|
Market Cap | 5.24T | 104.4B |
Volume | 16.9M | — |
Lot | 169.01K | — |
Turnover | 13.99B | — |
Average Price | 827.58 | — |
Value | 13.99B | — |
Indicative Equilibrium Price | 825 | — |
Indicative Equilibrium Volume | 1.8K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Multi Spunindo Jaya Tbk.
PT Multi Spunindo Jaya Tbk (the Company), was established based on Notarial Deed of WahyudiSuyanto, S.H., No. 102 dated March 7, 1997. The Company started its commercial operation in 1999. The Company’s immediate parent company is PT Maju Selaras Jayamerta and the ultimate controlling shareholder of the Company is Sasongko Basuki.
Read more on MSJA →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
